Study at v1.0.0
NCT00083421
6b5ccd2ebf31ef6a0a007fea3aff3be7b46b39d6e0d5b1f6b709e0c913f5a951 · where else it appears
Data
{
"briefSummary": "The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.",
"completionDate": "2007-07",
"conditions": [
"Alzheimer's Disease"
],
"enrollmentCount": 647,
"enrollmentType": "ACTUAL",
"nctId": "NCT00083421",
"phase": "PHASE2",
"sponsorId": "ono-pharma-usa-inc",
"startDate": "2004-06",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Effects of ONO-2506PO in Patients With Alzheimer's Disease",
"url": "https://clinicaltrials.gov/study/NCT00083421"
}History in this collection
- addedv1.0.0Jun 12, 2026this version